Fundraising Fox

BioAge Labs

NASDAQ: BIOA

Richmond, US · Delaware corporation · 9 known investors

bioagelabs.com

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.

BiotechHealthtechLongevityin /bioage-labs@bioagelabs

Founders & leadership

KFKristen Fortney, PhD
Kristen Fortney, PhDCo-Founder, CEO
EMEric Morgen, MD
Eric Morgen, MDCo-Founder, COO
EM
Eric MorgenDirector
DG
Dov GoldsteinExecutive Officer
JC
Jason ColomaDirector
KF
Kristen FortneyExecutive Officer, Director
RH
Rehka HemrajaniDirector
PE
VP
Vijay PandeDirector
JH
James HealyDirector

Investors · 9

Competitors · 8

by search overlap

Companies competing with BioAge Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$194.4MraisedFeb 2024 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric MorgenDirector
  • Dov GoldsteinExecutive Officer
  • Jason ColomaDirector
  • Kristen FortneyExecutive Officer, Director
  • Patrick EnrightDirector
  • Vijay PandeDirector
  • Rehka HemrajaniDirector
  • James HealyDirector
Offering amount
$194.4M
Amount sold
$194.4M
Minimum investment
$3
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news